{"transactions":[{"id":4619382,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-09-16T20:27:27.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":300000,"price":4.72,"value":1416000.0,"ownership":{"direct":false,"nature":"By Trust."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee."}],"balance_after":1170056,"source":{"system":"sec-edgar","filing":"0001971702-26-000017","document":"wk-form4_1789590444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971702/000197170226000017/wk-form4_1789590444.xml","form_type":"4"}},{"id":707795,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-07-16T20:55:24.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":24215,"price":4.67,"value":113084.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (\"RSUs\") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":1145699,"source":{"system":"sec-edgar","filing":"0001801170-26-000178","document":"wk-form4_1784235321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000178/wk-form4_1784235321.xml","form_type":"4"}},{"id":759740,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-05-28T22:40:07.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":220426,"price":3.99,"value":879499.74,"ownership":{"direct":false,"nature":"By Trust."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $3.92 to $4.04, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee."}],"balance_after":1390056,"source":{"system":"sec-edgar","filing":"0001971702-26-000010","document":"wk-form4_1780008005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170226000010/wk-form4_1780008005.xml","form_type":"4"}},{"id":806763,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-04-16T20:07:01.000Z","date":"2026-04-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":23463,"price":2.04,"value":47864.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1169914,"source":{"system":"sec-edgar","filing":"0001971702-26-000007","document":"wk-form4_1776370018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170226000007/wk-form4_1776370018.xml","form_type":"4"}},{"id":815369,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-04-03T20:25:26.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":267766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1.   Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030."}],"balance_after":1193377,"source":{"system":"sec-edgar","filing":"0001971702-26-000006","document":"wk-form4_1775247922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170226000006/wk-form4_1775247922.xml","form_type":"4"}},{"id":836477,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-03-17T20:27:13.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":100195,"price":1.98,"value":198386.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022."}],"balance_after":925611,"source":{"system":"sec-edgar","filing":"0001971702-26-000003","document":"wk-form4_1773779231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170226000003/wk-form4_1773779231.xml","form_type":"4"}},{"id":934971,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2026-01-20T22:46:04.000Z","date":"2026-01-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":25868,"price":2.81,"value":72689.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1025806,"source":{"system":"sec-edgar","filing":"0001801170-26-000025","document":"wk-form4_1768949161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000025/wk-form4_1768949161.xml","form_type":"4"}},{"id":966965,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-12-16T21:20:35.000Z","date":"2025-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":98411,"price":2.7,"value":265709.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1051674,"source":{"system":"sec-edgar","filing":"0001971702-25-000011","document":"wk-form4_1765920033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170225000011/wk-form4_1765920033.xml","form_type":"4"}},{"id":1007768,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-11-04T21:46:13.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":27930,"price":3.53,"value":98592.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2025."}],"balance_after":1150085,"source":{"system":"sec-edgar","filing":"0001971702-25-000009","document":"wk-form4_1762292771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170225000009/wk-form4_1762292771.xml","form_type":"4"}},{"id":1007767,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-11-04T21:46:13.000Z","date":"2025-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":96448,"price":3.53,"value":340461.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein.  Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025."}],"balance_after":1178015,"source":{"system":"sec-edgar","filing":"0001971702-25-000009","document":"wk-form4_1762292771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170225000009/wk-form4_1762292771.xml","form_type":"4"}},{"id":1016283,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-10-17T20:38:13.000Z","date":"2025-10-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":92181,"price":2.8,"value":258106.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1274463,"source":{"system":"sec-edgar","filing":"0001971702-25-000006","document":"wk-form4_1760733489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000197170225000006/wk-form4_1760733489.xml","form_type":"4"}},{"id":1038969,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-09-16T20:19:10.000Z","date":"2025-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":98412,"price":3.06,"value":301140.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1573425,"source":{"system":"sec-edgar","filing":"0001801170-25-000227","document":"wk-form4_1758053947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000227/wk-form4_1758053947.xml","form_type":"4"}},{"id":1075944,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-08-04T20:45:25.000Z","date":"2025-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":27930,"price":2.89,"value":80717.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":1671837,"source":{"system":"sec-edgar","filing":"0001801170-25-000186","document":"wk-form4_1754340322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000186/wk-form4_1754340322.xml","form_type":"4"}},{"id":1081812,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-07-24T20:11:12.000Z","date":"2025-07-23","kind":"sale","planned":true,"acquired":false,"shares":91197,"price":3.32,"value":302774.04,"ownership":{"direct":false,"nature":"By Trust."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.40, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee."}],"balance_after":1403701,"source":{"system":"sec-edgar","filing":"0001801170-25-000176","document":"wk-form4_1753387862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000176/wk-form4_1753387862.xml","form_type":"4"}},{"id":1081811,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-07-24T20:11:12.000Z","date":"2025-07-22","kind":"sale","planned":true,"acquired":false,"shares":118600,"price":3.29,"value":390194.0,"ownership":{"direct":false,"nature":"By Trust."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.37, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee."}],"balance_after":1494898,"source":{"system":"sec-edgar","filing":"0001801170-25-000176","document":"wk-form4_1753387862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000176/wk-form4_1753387862.xml","form_type":"4"}},{"id":1089037,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-07-10T23:24:38.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":15203,"price":3.26,"value":49561.78,"ownership":{"direct":false,"nature":"By Trust."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.27, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee."}],"balance_after":1613498,"source":{"system":"sec-edgar","filing":"0001801170-25-000170","document":"wk-form4a_1752189870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000170/wk-form4a_1752189870.xml","form_type":"4/A","original_submission_date":"2024-09-17"}},{"id":1089036,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-07-10T23:24:38.000Z","date":"2024-09-13","kind":"grant","planned":true,"acquired":true,"shares":379866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date.  This Amendment is being filed to reflect the full number of RSUs that were achieved."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 10, 2025."}],"balance_after":1699767,"source":{"system":"sec-edgar","filing":"0001801170-25-000170","document":"wk-form4a_1752189870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000170/wk-form4a_1752189870.xml","form_type":"4/A","original_submission_date":"2024-09-17"}},{"id":1107226,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-06-17T21:26:06.000Z","date":"2025-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":98411,"price":2.89,"value":284407.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3138535,"source":{"system":"sec-edgar","filing":"0001801170-25-000159","document":"wk-form4_1750195559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000159/wk-form4_1750195559.xml","form_type":"4"}},{"id":1160693,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-05-02T20:34:22.000Z","date":"2025-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":26593,"price":3.4,"value":90416.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 30, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in two equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3236946,"source":{"system":"sec-edgar","filing":"0001801170-25-000114","document":"wk-form4_1746218055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000114/wk-form4_1746218055.xml","form_type":"4"}},{"id":1198197,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-03-18T20:51:06.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":80524,"price":3.66,"value":294717.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3263539,"source":{"system":"sec-edgar","filing":"0001801170-25-000072","document":"wk-form4_1742331058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000072/wk-form4_1742331058.xml","form_type":"4"}},{"id":1283424,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2025-02-04T21:15:58.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":24470,"price":4.39,"value":107423.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3344063,"source":{"system":"sec-edgar","filing":"0001801170-25-000036","document":"wk-form4_1738703750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000036/wk-form4_1738703750.xml","form_type":"4"}},{"id":1327757,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2024-12-17T21:17:42.000Z","date":"2024-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":98217,"price":3.11,"value":305454.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3368533,"source":{"system":"sec-edgar","filing":"0001801170-24-000249","document":"wk-form4_1734470256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000249/wk-form4_1734470256.xml","form_type":"4"}},{"id":1376769,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2024-11-04T22:47:10.000Z","date":"2024-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":111496,"price":4.12,"value":459363.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":3466750,"source":{"system":"sec-edgar","filing":"0001801170-24-000228","document":"wk-form4_1730760424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000228/wk-form4_1730760424.xml","form_type":"4"}},{"id":1384513,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Counterpart Health"}}],"security":"Class A Common Stock","published_at":"2024-10-17T20:16:42.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":726114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A common stock underlying a time-based restricted stock unit award (\"RSUs\"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028."}],"balance_after":3578246,"source":{"system":"sec-edgar","filing":"0001801170-24-000212","document":"wk-form4_1729196197.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000212/wk-form4_1729196197.xml","form_type":"4"}},{"id":1404382,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:07:49.000Z","date":"2024-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":98217,"price":2.99,"value":293668.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of the restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022.  The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2852132,"source":{"system":"sec-edgar","filing":"0001801170-24-000192","document":"wk-form4_1726603663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000192/wk-form4_1726603663.xml","form_type":"4"}},{"id":1404381,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:07:49.000Z","date":"2024-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":93180,"price":2.99,"value":278608.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above."}],"balance_after":2950349,"source":{"system":"sec-edgar","filing":"0001801170-24-000192","document":"wk-form4_1726603663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000192/wk-form4_1726603663.xml","form_type":"4"}},{"id":1404380,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-17T20:07:49.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":189934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date."}],"balance_after":3043529,"source":{"system":"sec-edgar","filing":"0001801170-24-000192","document":"wk-form4_1726603663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000192/wk-form4_1726603663.xml","form_type":"4"}},{"id":1474340,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-18T20:57:21.000Z","date":"2024-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":69148,"price":1.09,"value":75371.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2024, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest  quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2853595,"source":{"system":"sec-edgar","filing":"0001801170-24-000128","document":"wk-form4_1718744234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000128/wk-form4_1718744234.xml","form_type":"4"}},{"id":1571755,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-18T20:41:45.000Z","date":"2024-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":74396,"price":0.73,"value":54309.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2024, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest  quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2922743,"source":{"system":"sec-edgar","filing":"0001801170-24-000071","document":"wk-form4_1710794498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117024000071/wk-form4_1710794498.xml","form_type":"4"}},{"id":1706569,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-18T21:52:40.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":96086,"price":1,"value":96086.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2023, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest  quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2997139,"source":{"system":"sec-edgar","filing":"0001801170-23-000119","document":"wk-form4_1702936350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000119/wk-form4_1702936350.xml","form_type":"4"}},{"id":1749287,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-03T21:00:39.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":440000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A amends the original Form 4, filed on November 2, 2023, solely to correct the CIK for the Reporting Person.  The original Form 4 inadvertently included the Registrant's CIK."}],"balance_after":3093225,"source":{"system":"sec-edgar","filing":"0001801170-23-000096","document":"wk-form4a_1699045230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117023000096/wk-form4a_1699045230.xml","form_type":"4/A","original_submission_date":"2023-11-02"}},{"id":1778592,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-18T21:20:36.000Z","date":"2023-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":96086,"price":1.13,"value":108577.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of  time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest  quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2653225,"source":{"system":"sec-edgar","filing":"0000895345-23-000534","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000534/form4.xml","form_type":"4"}},{"id":1851186,"issuer":{"id":4419,"kind":"organization","name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","symbol":"CLOV"},"owners":[{"id":30022,"kind":"person","name":"Wai Conrad","position":1,"cik":"0001971702","reported_name":"Wai Conrad","relationship":{"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-16T20:02:49.000Z","date":"2023-06-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":86763,"price":0.94,"value":81557.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units (\"RSUs\") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date."}],"balance_after":2749311,"source":{"system":"sec-edgar","filing":"0000895345-23-000390","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801170/000089534523000390/form4.xml","form_type":"4"}}]}